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Abstract
High-protein diets are effective in achieving weight loss which is mainly explained by increased satiety and thermogenic
effects. Recent studies suggest that the effects of protein-rich diets on satiety could be mediated by amino acids like leucine
or arginine. Although high-protein diets require increased intestinal amino acid absorption, amino acid and peptide
absorption has not yet been considered to contribute to satiety effects. We here demonstrate a novel finding that links
intestinal peptide transport processes to food intake, but only when a protein-rich diet is provided. When mice lacking the
intestinal peptide transporter PEPT1 were fed diets containing 8 or 21 energy% of protein, no differences in food intake and
weight gain were observed. However, upon feeding a high-protein (45 energy%) diet, Pept1
2/2 mice reduced food intake
much more pronounced than control animals. Although there was a regain in food consumption after a few days, no weight
gain was observed which was associated with a reduced intestinal energy assimilation and increased fecal energy losses.
Pept1
2/2 mice on high-protein diet displayed markedly reduced plasma leptin levels during the period of very low food
intake, suggesting a failure of leptin signaling to increase energy intake. This together with an almost two-fold elevated
plasma arginine level in Pept1
2/2 but not wildtype mice, suggests that a cross-talk of arginine with leptin signaling in brain,
as described previously, could cause these striking effects on food intake.
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Introduction
Numerous studies have demonstrated that diets with a high
protein content provide higher satiety levels (at least short term)
than the other macronutrients [1,2]. In addition, it has been
shown that protein-rich diets can promote weight loss and cause
changes in body composition [1]. Intake of dietary protein is
sensed in the intestine with concomitant secretion of gastrointes-
tinal hormones and activation of visceral processes that alter
gastric motility, stimulate pancreatic secretion, mediate periph-
eral effects and contribute to satiety [3–5]. Mainly PYY and
CCK but also insulin and leptin are discussed to play a
prominent role in satiety control [6–8]. Yet, in most cases
feeding high-protein diets revealed negligible effects on circulat-
ing levels of these hormones [9–11]. Recently, neuronal pathways
in the brainstem nucleus of the solitary tract and hypothalamic
arcuate nucleus were shown to be activated by high-protein diets
[12]. Amongst the possible dietary signals for this hypothalamic
sensing, the amino acid leucine has received particular attention.
It was demonstrated that leucine contributes to food intake
control via AMP-activated protein kinase and mammalian target
of rapamycin when supplied to hypothalamic centers [13,14].
Since plasma levels of branched chain amino acids (BCAA),
including leucine, increase when dietary protein supply is
increased and brain leucine levels follow plasma levels, a role of
leucine in central regulation of satiety seems plausible. However
conflicting results on the role of leucine were obtained in animal
studies in which extra leucine was supplied by the diet to affect
food intake and body weight [15,16]. Additionally high-protein
intake causes also major adaptations in metabolic processes in
intestine and liver associated with changes in plasma levels of a
variety of amino acids [17]. Although protein-rich diets challenge
the digestive tract with large quantities of amino acids and short
chain peptides for uptake into epithelial cells and into circulation,
a contribution of intestinal transport processes to food intake
control has never been anticipated.
Intestinal protein digestion delivers short chain peptides and
free amino acids to epithelial cells. Amino acids are taken up
through numerous amino acid transporters acting as symporters or
antiporters [18]. For absorption of di- and tripeptides only one
transport system in the intestine, designated as PEPT1 (SLC15A1)
is known [19]. PEPT1 is a low-affinity but high-capacity transport
system and handles essentially all possible protein-derived di- and
tripeptides, but also a variety of peptidomimetics like aminoce-
phalosporins and various prodrugs [20]. Peptide transport is
electrogenic by charge movement as it involves the cotransport of
protons [21]. PEPT1 in the intestine is subject to regulation by a
variety of hormones and cytokines [22], but also by the dietary
protein content. As demonstrated by Erickson et al, mRNA
expression and transport rate of PEPT1 in rat intestine increases
1.5 to 2-fold when animals received a high-protein (50 energy%)
diet as compared to a 4% protein diet [23].
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26407Although the structure and function of PEPT1 has been studied
in detail [21], its contribution to overall amino acid absorption is
still unknown. The PEPT1-deficient model organism Caenorhabditis
elegans showed reduced body size, impaired brood size and a
retarded postembryonic development [24]. We recently reported
that the lack of intestinal peptide transport in Pept1
2/2 mice is not
compensated by changes in mRNA expression or transport
capacity of intestinal amino acid transporters. Phenotyping of
Pept1
2/2 mice did not reveal any impairments in reproduction,
body weight or any other anthropometric or clinical chemistry
measures when animals were fed a standard high-carbohydrate
diet [25]. Yet, plasma concentrations of amino acids were
increased in Pept1
2/2 when compared to Pept1
+/+ mice, suggesting
an altered systemic amino acid handling. Moreover, administra-
tion of an acute high protein load via gastric gavage also caused
differences in plasma concentrations of several amino acids such as
citrulline and arginine and most prominently of proline [26,27].
Based on this finding, feeding trials with Pept1
2/2 animals with
variations in dietary protein content were performed and we here
report striking diet-dependent effects on food intake and weight
gain that were further characterized by biochemical analysis.
Taken together our findings suggest that the intestinal peptide
transporter PEPT1 is part of a metabolic network that affects food
intake particularly when high-protein diets are consumed.
Results
Effect of a high-protein diet on food intake and body
weight in Pept1
2/2 and Pept1
+/+ mice
Determination of food intake and body weight changes in
Pept1
2/2 mice fed for 5 days a LP or C diet did not show any
significant alterations when compared to wildtype animals.
However when animals were provided with a HP diet, food
intake rates immediately declined in all animals but more
pronounced in Pept1
2/2 animals (Figure 1). Whereas wildtype
animals increased food consumption again after 2 days, Pept1
2/2
mice reduced food intake even further over 4 days (Figure 1A).
This led in Pept1
2/2 animals also to a decrease in body weight
(Figure 1B) and reduced feces excretion (Figure 1C). No diffe-
rences in water consumption were observed, neither between diets
nor genotypes (data not shown). A second feeding trial conducted
over a 18 day period revealed a similar initial major reduction in
food intake for 4 days in Pept1
2/2 mice while animals thereafter
increased food consumption to reach the same intake rates as
observed in wildtype animals (Figure 2A), yet, they failed to show
any significant weight gain over the entire feeding trial (Figure 2B).
Analysis of energy content in feces determined by bomb
calorimetry revealed significantly higher energy losses in Pept1
2/2
than in Pept1
+/+ animals. At day 5 on the HP diet energy density in
feces accounted to 12.20 kJ/g in wildtype animals and 15.23 kJ/g
(P,0.001) in Pept1
2/2 mice and these differences remained to the
end of the experiment accounting at day 18 to 12.19 kJ/g feces in
Pept1
+/+ and 14.68 kJ/g feces (P,0.001) in Pept1
2/2 mice. In
addition, energy balance calculations with the data from the 5 day
feeding trial revealed that reduced energy assimilation and
Figure 1. Pept1
2/2 animals on high-protein diet show major
changes in metabolic parameters. Metabolic parameters of male
mice on low-protein (LP =8% protein energy), control (C =21% protein
energy) and high-protein (HP=45% protein energy) diet were
determined in Pept1
+/+ (wt) and Pept1
2/2 (ko) animals. During 5 days
on the different diets, food intake (A), weight (B), and feces excretion (C)
were determined (n=10). Data are presented as mean6SEM. *P,0.05,
$P,0.01,
1P,0.001.
doi:10.1371/journal.pone.0026407.g001
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available to PEPT1-deficient animals on the HP diet (Table 1).
Changes in plasma parameters in Pept1
2/2 mice
Clinical chemistry data of mouse plasma collected after 5 days
revealed lower alkaline phosphatase levels in Pept1
2/2 animals,
both on C and HP diet. In addition Pept1
2/2 mice, when fed the
HP diet displayed also significantly decreased levels of amylase and
glucose. In contrast, wildtype animals on HP diet showed higher
blood urea nitrogen levels when compared to mice on C diet (HP:
41.866.2 mg/dl vs. C: 3164.1 mg/dl, P,0.001), whereas blood
urea nitrogen levels in Pept1
2/2 animals on HP diet were
comparable to those on C diet (HP: 31.865.6 mg/dl vs. C:
30.463.8 mg/dl; P,0.001). These data are summarized in
Figure 3. When blood urea nitrogen levels were determined after
18 days, genotype effects were no longer detectable and enyzme
activities did also not show any more differences (data not shown).
Yet, independent of genotype, mice on the HP diet displayed
significant elevated blood urea nitrogen concentrations (HP:
4464.3 mg/dl; vs. C: 2663.6, mg/dl; P,0.001).
High-protein diet alters plasma levels of amino acids and
derivatives
To assess alterations in systemic amino acid levels of mice fed
diets with different protein contents, we analyzed plasma samples
by LC-MS/MS. As a highly consistent and genotype-specific
finding, we observed an almost two-fold increase in plasma levels
of arginine in Pept1
2/2 mice on both, C (ko: 90629.8 mmol/l vs.
wt: 44.8622.8 mmol/l, P=0.002) and HP diet (ko: 96.96
42.6 mmol/l vs. wt: 53.1619.1 mmol/l, P=0.008) after 5 days
(Table S1). Genotype-independent effects of the diets were found
for valine, leucine, isoleucine, but also for alpha-aminobutyric acid
and glutamine with significantly increased levels in plasma
obtained from animals on the HP diet. Decreased plasma levels
were found for anserine and hydroxyproline. After 18 days of
feeding, alpha-aminobutyric acid levels as well as leucine and
Figure 2. Food intake and body weight during feeding Pept1
2/2 animals a high-protein diet. Food intake (A) and body weight (B) of male
Pept1
+/+ (wt) and Pept1
2/2 (ko) mice on control (C=21% protein energy) or high-protein (HP=45% protein energy) diet recorded over the 18 days
feeding trial. Data are presented as the mean6SEM. *P,0.05,
$P,0.01,
1P,0.001.
doi:10.1371/journal.pone.0026407.g002
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and ethanolamine showed higher levels in animals on control than
on HP diet irrespective of genotypes. Representative plasma
amino acid levels at days 5 and 18 when feeding the HP diet are
summarized in Figure 4.
Altered hepatic amino acid levels and enzyme activities
in Pept1
2/2 animals
Amino acid levels and enzyme acitivities in liver tissue samples
were determined and revealed that after 18 days of feeding the HP
diet, 10 out of 28 quantified metabolites were changed (Table S3)
with significantly decreased concentrations of methionine, citrul-
line and taurine but increased levels of leucine, tyrosine, serine,
asparagine, ethanolamine, gamma-aminobutyric acid and the urea
cycle intermediate ornithine. However, as shown in Table 2,
neither urea levels in liver nor hepatic enzyme activities revealed
any genotype- or diet-specific effects.
Concentrations of
14N and
15N-lableled amino acids in
portal blood after
15N-protein gavage
To determine whether any changes in intestinal amino acid
absorption and/or metabolism can be detected, portal vein plasma
of Pept1
+/+ and Pept1
2/2 mice was analyzed by LC-MS/MS.
Plasma samples were obtained 15 and 30 min after administration
of a
15N-labeled yeast protein extract provided by gavage. For
14N-labeled amino acids differences between genotypes were only
detectable for lysine after 15 min (ko: 294.8622.1 mmol/l vs. wt:
197.6642.2 mmol/l, P=0.002) and arginine after 30 min (ko:
36.664.1 mmol/l vs. wt: 25.167.6 mmol/l, P=0.02). For
15N-
labeled amino acids in portal blood only isoleucine showed slightly
reduced concentrations with a genotype-specific effect at 15 min
(ko: 29.864.2 mmol/l vs. wt: 36.663.8 mmol/l, P=0.03) but none
of the other amino acids. Taken together, neither levels of
14N nor
15N-labeled amino acids determined in portal blood of Pept1
+/+
and Pept1
2/2 mice revealed remarkable differences (Figure S1)
that could have indicated altered amino acid delivery to
circulation.
Decreased leptin levels in Pept1
2/2 animals
To assess whether selected hormones or adipokines revealed
changes that could be associated with the differences in food
intake, ghrelin, insulin and leptin levels were determined. As
shown in Figure 5, neither ghrelin nor insulin levels changed,
whereas leptin levels differed significantly between Pept1
+/+ and
Pept1
2/2 mice. Plasma leptin levels dropped significantly in
PEPT1-deficient animals on the HP diet after 24 h to
2.261.4 ng/ml as compared to wildtype animals with
7.662.4 ng/ml (P=0.001). This effect, yet not reaching signifi-
cance was also observed on control diet in both, the fed (ko: 2.66
2.1 ng/ml vs. wt: 5.661.6 ng/ml) and the fasted state (ko:
2.561.7 ng/ml vs. wt: 5.762.4 ng/ml).
Figure 3. Decreased activities of enzymes and glucose in plasma of Pept1
2/2 animals. Enzyme and metabolite activities in plasma of
Pept1
+/+ (wt) and Pept1
2/2 (ko) animals fed a control (C=21% protein energy) or high-protein (HP=45% protein energy) diet were analyzed. Alkaline
phosphatase (ALP), amylase, glucose and blood urea nitrogen (BUN) were determined after 5 days on the high-protein diet (n=10). Data are
presented as mean6SD. (N) indicate outlier. *P,0.05,
$P,0.01,
1P,0.001.
doi:10.1371/journal.pone.0026407.g003
Table 1. Energy assimilation in Pept1
+/+ and Pept1
2/2 animals on low-protein (LP=8% energy from protein), control (C=21%
energy from protein) or high-protein (HP=45% energy from protein) diet.
Group Genotype
Sum of energy intake
(kJ)
Sum of energy
excretion (kJ)
Sum of energy
assimilation (kJ)
Energy difference
over 5 days (kJ)
LP Pept1
+/+ 387.23 27 360.23 7.62
Pept1
2/2 379.6 26.66 352.61
C Pept1
+/+ 409.98 29.83 380.15 28.36
Pept1
2/2 382.08 30.29 351.79
HP Pept1
+/+ 351.53 25.16 326.37 71.05
Pept1
2/2 276.08 20.76 255.32
The given values are the sum of the 5 day lasting feeding trial. Energy calculations of Pept1
+/+ and Pept1
2/2 animals on low-protein (8% protein energy), control (21%
protein energy) and high-protein (45% protein energy) diet for 5 days were analyzed (n=10). Data are presented as sum of energy intake, energy excretion and energy
assimilation over 5 days of feeding the diets.
doi:10.1371/journal.pone.0026407.t001
Effects of a High-Protein Diet on Pept1
-/- Mice
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Energy intake is strongly affected by diet composition and
numerous studies in animals and humans have demonstrated that
protein-rich diets initiate higher satiety levels than other
macronutrients [1,28–31]. Amongst the various mechanisms
proposed to mediate this effect (for review see Thome ´ [32]) two
hypotheses have recently received considerable attention. One
involves the hypothalamic sensing of the increased leucine
availability on high-protein diets, the other is based on an
increased intestinal gluconeogenesis sensed in the portal system
and transmitted via afferences of the vagus nerve to brain. We here
provide evidence that intestinal transport mechanisms for nutrients
involving the intestinal peptide transporter PEPT1 participate in
the control of food intake on a high-protein diet. Only in response
to a high-protein (45 energy%) diet, Pept1
2/2 animals showed a
much more pronounced reduction in food intake than wildtype
animals. Although Pept1
2/2 mice increased food intake again after
5 days on the HP diet with a similar daily caloric intake as wildtype
animals, body weight reduction in Pept1
2/2 animals sustained,
whereas wildtype animals increased body weight after a few days.
In parallel to the decline in food intake, body weight decreased
with a regain after 4 to 5 days when food intake increased again.
Despite very similar food and thus caloric intake after the regain, a
significantly increased energy loss in feces on all diets and in
particular on the HP diet in Pept1
2/2 mice was observed. This
suggests that energy assimilation in the intestine is modestly
impaired and that the lack in weight gain on the high-protein diet,
despite similar food intake rates as in control animals after 5 to 6
days is a consequence of this. However, the data also suggest that
Pept1
2/2 mice are unable to regulate energy intake adequately for
preventing weight loss or for increasing body weight after the
regain of food intake. To assess whether hormones that a part of
satiety sensing are altered in PEPT1-deficient mice we analyzed
non-fasting and fasting plasma ghrelin and insulin levels but did
not observe any differences, neither between diets nor genotypes.
In contrast, leptin, a key signaling molecule in energy homeostasis
and regulation of food intake [33] displayed significantly decreased
plasma levels in Pept1
2/2 animals on the high-protein diet. Leptin
levels generally follow fat mass changes but also decline quickly
following food deprivation. Our data suggest that a PEPT1-
deficiency could antagonize leptin actions as low plasma leptin
levels should lead to an increase in food intake. Most interestingly,
leptin was shown to regulate PEPT1 expression and to alter its
transport capacity in the intestine [34–36] arguing that amino acid
absorption in the intestine mediated by PEPT1 could be part of
the body’s response to changes in leptin levels that participate in
control of energy homeostasis.
Various studies have proposed that signalling processes initiated
in the portal vein and transmitted from there via afferences of the
vagus nerve to brain may provide satiety signals [12,32,37]. Such a
mechanims was also suggested for the hypophagic effects of high-
protein diets via an increased intestinal gluconeogenesis rate and
elevated portal glucose concentrations in rats [38–40]. However,
these findings have been challenged by a lack of evidence for a
significant intestinal gluconeogenesis from the stable-isotope
labeled glucogenic amino acid glutamine in two strains of fasted
rats [41]. This confirmed other studies, that could also not
Figure 4. Changed plasma amino acids after 5 and 18 days on high-protein diet in Pept1
2/2 animals. By LC-MS/MS plasma amino acid
concentrations of Pept1
+/+ (wt) and Pept1
2/2 (ko) animals a high-protein (45% protein energy) diet were analyzed (n=3–10). Plasma amino acid
profiles of arginine (Arg), leucine (Leu) and the sum of all detectable amino acids (Sum) of Pept1
2/2 (ko) and Pept1
+/+ (wt) animals on high-protein
(HP) diet for 5 and 18 days are depicted. Data are presented as mean6SD. (N) indicate outlier. *P,0.05,
$P,0.01,
1P,0.001.
doi:10.1371/journal.pone.0026407.g004
Table 2. Enzyme activities and urea levels in liver tissue of Pept1
+/+ and Pept1
2/2 animals after feeding a high-protein diet (45%
energy from protein) for 18 days.
Parameter Control High-protein
Pept1
+/+ Pept1
2/2 Pept1
+/+ Pept1
2/2
GDH (mU/mg) 752.36109.8 738.0679.8 708.7682.7 955.86119.2
AST (mU/mg) 2422.76338.2 2475.16560.2 1965.86189.9 2141.86351.2
ALT (mU/mg) 784.3645.7 797.2618.3 623.4619.4 643.2665.0
Urea (mmol/mg) 13.960.9 10.060.9 16.162.1 15.064.0
Enzyme activities of glutmate dehydrogenase (GDH), alanine aminotransferase (AST), alkaline aminotransferase (ALT) as well as urea levels were determined in liver
tissue collected from Pept1
+/+ and Pept1
2/2 animals kept on standard diet (21% protein energy) and high-protein (45% protein energy) diet. All data are presented as
mean 6 SD (n=3 animals). P-value was obtained by unpaired Student’s t-test.
doi:10.1371/journal.pone.0026407.t002
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high-protein diet [42]. We recently reported that there were
essentially no differences in the apperance rates of amino acids in
the portal vein and peripheral plasma between wildtype and
PEPT1-deficient animals [26]. We also administered a
15N-labeled
yeast extract to wildtype and PEPT1-deficient animals by gavage
and here report the extended analysis of samples for stable isotope
labeled amino acids in portal blood with emphasis on glucogenic
and non-proteinogenic amino acids. Since there were no detectable
differences between genotypes in any of the relevant amino acids we
conclude, that despite the questionable role of intestinal gluconeo-
genesis, this process seems not to account to the satiety effect of the
high-protein diet in PEPT1-deficient animals reported here.
In addition to peptide uptake, mediated by PEPT1, a large
number of apical and basolateral amino acid transporters
contribute to amino acid delivery into systemic circulation (for
reviews see [18,43]). After portal delivery, selective hepatic
extraction of amino acids allows only some of the 20 proteinogenic
amino acids to change in peripheral blood in the absorptive phase.
Amongst them are the BCAA as well as the aromatic amino acids.
Especially the BCAA leucine has been proposed to contribute to
satiety control. Administration of leucine into hypothalamic
regions in rats was shown to increase brain mTOR signaling
leading to a decrease in food intake and body weight suggesting
that low leucine levels in brain may initiate mechanisms that
stimulate food intake whereas high levels can increase satiety [13].
However, this finding contradicts with clinical experiences in
various human diseases in which supplementing BCAA in patients
generally caused an increase in food intake [44,45]. Moreover, a
supplementation of leucine in a diet with otherwise normal protein
content failed to show in mice any effect on food intake or weight
gain [46]. When provided in drinking water to mice fed either a
control or a high-fat diet, leucine supplementation did also not
reveal effects on food intake but improved some metabolic
parameters in animals on the high-fat diet [47]. In the present
study plasma amino acid profiling in animals on high-protein or
control diet after 5 or 18 days revealed that plasma BCAA and in
particular leucine levels increased significantly on the high-protein
diet (P=0.02) without differences by genotype. This means that
despite almost identical plasma leucine levels, Pept1
2/2 mice
reduced food intake much more pronounced than wildtype
animals over the first 5 days of feeding the HP diet, suggesting
that increased plasma leucine per se cannot account for the effects
of HP diets on satiation.
To assess whether any changes in liver metabolism can be
associated with the diet effects in PEPT1-deficient animals we
analyzed hepatic amino acid levels and enzyme activities. Protein-
rich diets require increased nitrogen elimination from amino acid
oxidation which is achieved by an increased delivery of nitrogen to
liver via glutamine, glutamate and alanine, an enhanced urea cycle
flux and increased renal excretion of urea. Blood urea concentra-
tions increased as expected in animals fed the HP diet but were
significantly lower in Pept1
2/2 animals (Fig. 3), while liver urea
levels did not reveal any genotype effect despite the diet-effects. A
recent proteome analysis of hepatic proteins in mice fed a normal
or a high-protein diet [48] identified carbamoylphosphate
synthetase 1 and ornithine aminotransferase with increased
protein levels, suggesting that the increased ornithine demand is
achieved from proline while ornithine-transcarbamoylase-activity
may limit efficient urea cycle flux. We here observed that citrulline
levels in liver tissue declined while ornithine levels increased upon
high-protein feeding, but without a genotype-specific effect.
Although liver arginine was below detection limit, Pept1
2/2 mice
displayed significantly increased plasma arginine levels on both,
control as well as high-protein diet at days 5 and 18. Plasma
citrulline levels were also significantly higher in Pept1
2/2 animals
at day 5 but no longer at day 18. Although portal blood arginine
and citrulline levels did not reveal any genotype-specific
differences, arginine concentrations in portal blood were much
lower than those in peripheral blood. This suggests that the
unusual high plasma levels of arginine in Pept1
2/2 mice originate
most likely from an increased renal arginine production from
citrulline. In this respect it is of interest that dietary L-arginine
supplementation (but not D-arginine) was shown to reduce food
intake in mice and this was attributed to altered nitric oxide (NO)
levels in brain [49]. Since brain arginine concentrations were
shown to change almost proportional to plasma arginine levels
[50], it is suggested that Pept1
2/2 mice may have also an increased
arginine level in brain. Most interestingly, delivery of arginine to
brain was shown to antagonize the leptin effects on food intake in
mice with a prominent regain of food consumption when co-
administered centrally with leptin [51]. Moreover, this effect was
abolished in NO-Synthase (nNOS) deficient mice and nNOS is
shown to be upregulated by leptin [52] and down-regulated by
food deprivation [53]. A similar effect of leptin on brain NO
production and food intake has also been shown in chicken
[54,55]. Since we observed low leptin levels in Pept1
2/2 mice only
when animals received the HP diet and when food intake was
Figure 5. Analysis of plasma hormone levels reveals lower leptin concentrations in Pept1
2/2 animals. Plasma samples of fasted (6 h
fasting period) and non-fasted Pept1
+/+ (wt) and Pept1
2/2 (ko) animals fed a control (C=21% protein energy) diet or a high-protein (HP=45% protein
energy) diet were analysed after 24 h for changes in ghrelin, leptin and insulin levels (n=6 animals). Data are presented as mean6SD. (N) indicate
outliers. *P,0.05,
$P,0.01,
1P,0.001.
doi:10.1371/journal.pone.0026407.g005
Effects of a High-Protein Diet on Pept1
-/- Mice
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26407markedly reduced while animals had almost two-fold higher
plasma arginine levels than wildtype controls, it is tempting to
speculate that the leptin-NOS axis in brain contributes to the
changes in food intake on protein-rich diets. Low leptin levels in
PEPT1-deficient mice on the HP diet most likely arise from the
very low food intake and the apparent ‘starvation condition’.
Plasma leptin levels are known to decrease radiply upon
starvation, yet, low leptin levels should increase food intake and
this response could be antagonized by the high plasma arginine
levels in Pept1
2/2 mice. Assuming in analogy to previous studies
that the low leptin levels in Pept1
2/2 mice and the food
deprivation cause major changes in NOS levels [51,53], then
NO production could in spite of the high arginine levels, be
reduced. This would be in line with the reported anorexic effects of
inhibitors of NOS [56,57]. Although we cannot provide conclusive
evidence for this hypothesis, our findings call for future studies
employing agonist and antagonists to alter brain NO pathways to
assess whether high plasma arginine levels in mice lacking PEPT1
indeed prevent proper leptin signalling for an adaptive increase in
food intake on protein-rich diets.
In summary, we have demonstrated that Pept1
2/2 animals on a
high-protein diet show a severe reduction in food intake compared
to wildtype animals that lasts for 5 to 6 days. Thereafter a regain in
food intake is observed but despite almost identical caloric intake
rates like the control animals, Pept1
2/2 mice do not show a weight
gain. This is probably a consequence of a yet unexplained
reduction in energy assimilation with an increased fecal energy loss
most pronounced on a high-protein diet. As a striking finding we
observed significantly elevated plasma arginine levels in Pept1
2/2
mice on both, control and HP diet and a markedly reduced plasma
leptin level only on the HP diet. Previous studies suggested a cross-
talk of leptin with the arginine-dependent NO system in brain as
part of the hypothalamic control loops that affect food intake.
Based on our data we hypothesize that during the food intake
reduction phase, the orexigenic action of low leptin levels is
blunted in PEPT1-deficient animals in association with the
constitutively increased plasma and possibly also brain arginine
levels. Further studies in Pept1
2/2 mice with high-protein diets
and extra injections of leptin or administration of NOS antagonists
could help to identify the mechanims underlying these genotype
and diet-specific effects described here.
Materials and Methods
Animals
Mice lacking PEPT1 were created by targeted disruption of the
Pept1 gene and obtained from Deltagen (San Mateo, California,
USA) [25]. Animals were backcrossed for 10 generations to
C57BL/6J background and maintained at 2262uC and a 12:12 h
light/dark cycle. All procedures were conducted according to the
German guidelines for animal care and approved by the state of
Bavaria (Regierung von Oberbayern) ethics committee (Reference
number: 55.2-1-54-2531-140-08).
Study design of feeding trials for 5 or 18 days
For the feeding studies Pept1
+/+ and Pept1
2/2 animals (n=10,
per diet and genotype) received semi-synthetic purified diets with
low (8% of energy; Ssniff E15202, Ssniff, Germany), medium (21%
of energy; Ssniff E15000) or high (45% of energy; Ssniff E15209)
protein content. Protein was isoenergetically exchanged for starch.
Mice were kept individually to allow recording of food intake and
water consumption. Throughout the study, mice had access to tap
water and food ad libitum. To allow for adaptation, animals
received the medium protein diet for 3 days. In the following 5
days, mice had free access to either low-protein (LP), medium=-
control (C) or high-protein (HP) diet. Body weight, food and water
consumption were monitored daily between 8:00 and 9:00 a.m.
Feces was collected daily. On the last day, blood was collected into
Li-Heparin coated tubes (Sarstedt, Nu ¨mbrecht, Germany) by
puncturing the retro-orbital sinus under isoflurane anaesthesia. In
the second feeding trial, lasting 18 days (n=3), only the C and HP
diet were given and metabolic parameters were measured daily.
Every 5 days, fecal samples were collected and on day 18 plasma
and tissue samples were taken.
Plasma amino acid analysis
By liquid chromatography-tandem mass spectrometry (LC-MS/
MS) (3200QTRAP LC/MS/MS, Applied Biosystems, USA) with
iTRAQ labeling for quantification, amino acids and derivatives in
plasma using the AA45/32 Kit, according to the manufacturer’s
instructions (Applied Biosystems, USA), were determined. The
data obtained were analyzed using the AnalystH 1.5 Software.
Analysis of portal blood for labeled amino acids derived
from an oral
15N-protein administration
Analysis of portal blood and tissue samples from jejunum,
duodenum and ileum collected from Pept1
+/+ and Pept1
2/2 mice
after administration of a
15N-yeast extract to mice via intragastric
gavage have been described previously [26]. Briefly, mice (n=6,
per group and genotype) received 8.83 mg
15N-labeled yeast
protein by gavage. After 15 and 30 min blood was collected from
portal vein and plasma samples were analyzed for labeled and
non-labeled amino acids via LC-MS/MS.
Measurement of AST, ALT and GDH activities and urea
In liver samples of mice receiving the C or the HP diet, enzyme
activities of aspartate aminotransferase (AST), alanine amino-
transferase (ALT) and glutamate dehydrogenase (GDH) were
analyzed. Samples were homogenized with 0.9% NaCl and
centrifuged (15 min, 14000 g). Supernatant was diluted 1:100 and
enzyme activities were determined with the GPT (ALT)
liquidUVTest #12012 and GOT (AST) liquiUV Test #12011
(both Human Gesellschaft fu ¨r Biochemica und Diagnostica,
Wiesbaden, Germany) and GDH FS #G82100 (Rolf Greiner
BioChemica GmbH, Flacht, Germany) according to the manu-
facturer’s instructions. Urea levels were analyzed from supernatant
without dilution with the Urea Liquicolor Test #10505 (Human
Gesellschaft fu ¨r Biochemica und Diagnostica, Wiesbaden, Ger-
many) according to the manufacturer’s instructions.
Clinical chemistry of plasma samples
A multiple analyte panel by the Piccolo xpress
TM Chemistry
analyzer (Abaxis, California, USA) was used for quantitative
determination of albumin, alkaline phosphatase (ALP), amylase,
aspartate aminotransferase (AST), calcium, creatinine, gamma
glutamyltransferase (GGT), glucose, total bilirubin, total protein,
blood urea nitrogen (BUN), and uric acid in plasma samples.
Hormone levels in plasma
In plasma of Pept1
+/+ and Pept1
2/2 animals (n=10), basal
hormone levels in fed and fasted state (fasting period: 6 h) on C
diet and after feeding the HP diet for 24 h were determined.
Samples were collected by puncturing the retro-orbital sinus under
isoflurane anaesthesia. Blood was collected in either Li-Heparin
coated tubes for insulin and leptin measurements, or in EDTA-
coated tubes (both Sarstedt, Nu ¨mbrecht, Germany) for ghrelin
determination. For ghrelin measurement, Pefabloc
H SC (Sigma-
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of 1 mg/ml. Insulin levels were determined using the Ultra
Sensitive Mouse Insulin ELISA Kit and leptin levels using the
Mouse Leptin ELISA Kit (both Crystal Chem Inc., Illinois, USA).
Ghrelin levels were assayed by the Rat/Mouse Ghrelin (active)
ELISA Kit (Millipore GmbH, Schwalbach, Germany).
Bomb calorimetry of feces samples
Gross energy content of feces was determined using a bomb
calorimeter (Parr 6300 Calorimeter, Parr Instrument Co., Illinois,
USA). Due to the low amount of feces in the feeding studies, dried
feces samples were pooled (per groups) and grinded with a pebble
mill (TissueLyser, Qiagen, Hilden, Germany), pressed to a pellet
(,1 g of feces) and analyzed by a bomb calorimeter.
Statistical analysis
Statistical analysis was performed using R 2.8 (R Foundation of
Statistical Computing [58]) and GraphPad Prism 4.01 (GraphPad
Software, California, USA). One-way or two-way ANOVA and
Tukey-test or unpaired Students t-test were used to test for
statistical significance. Data are presented as mean6SD unless
stated otherwise.
Supporting Information
Figure S1 Amino acid appearance in plasma after
administration of a low dose of
15N-labeled protein.
Analysis of
14N and
15N labeled amino acids from plasma of portal
vein 15 (A) and 30 min (B) after administration of
15N-labeled
protein (8.83 mg) by gavage in 12h-fasted Pept1
+/+ (wt) and Pept1
knockout (ko) animals (n=5 animals per timepoint and genotype).
Cit, citrulline; Sum, sum of all measured amino acids. (N) indicate
outlier. Data are presented as mean 6 SD. *P,0.05,
$P,0.01,
1P,0.001.
(TIF)
Table S1 Plasma amino acid concentrations of male
Pept1
+/+ and Pept1
2/2 animals after 5 days on control or
high-protein diet. By LC-MS/MS plasma amino acid concen-
trations of Pept1
+/+ and Pept1
2/2 animals on control (21% energy
from protein) or high-protein (45% energy from protein) diet for 5
days were analyzed (n=10). Data shows all analyzed amino acids
plus sum of all amino acids.
(DOC)
Table S2 Plasma amino acid concentrations of male
Pept1
+/+ and Pept1
2/2 animals on control or high-
protein diet for 18 days. After feeding a control (21% energy
from protein) or high-protein (45% energy from protein) diet for
18 days plasma amino acid concentrations of Pept1
+/+ and Pept1
2/2
animals were analyzed by LC-MS/MS (n=3). Data shows all
analyzed amino acids plus sum of all amino acids.
(DOC)
Table S3 Concentrations of liver amino acids and
derivatives of Pept1+/+ and Pept12/2 animals on
control or high-protein diet after 18 days of feeding. By
LC-MS/MS liver amino acid concentrations of Pept1+/+ and
Pept12/2 animals on control (21% energy from protein) or high-
protein (45% energy from protein) diet were analyzed. Data shows
all analyzed amino acids plus sum of all amino acids. Data are
presented as mean6SD. (n=3).
(DOC)
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